Comparison of Laryseal Pro and Ambu AuraGain in Elective Ophthalmic Surgeries | ||||
| SVU-International Journal of Medical Sciences | ||||
| Volume 8, Issue 2, July 2025, Page 145-159 PDF (420.17 K) | ||||
| Document Type: Original research articles | ||||
| DOI: 10.21608/svuijm.2025.394807.2200 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Reham Ali Abdelhaleem Abdelrahman   ; Samar Talaat Mostafa Elsrogy; Naser Mohammed Dobal; Maha Mohammed Ismail Youssef
| ||||
| Department of Anesthesia, Surgical ICU and Pain Management, Faculty of Medicine, Cairo University, Kasr Al-Ainy, 11562, Cairo, Egypt. | ||||
| Abstract | ||||
| Background: Ambu AuraGain is a widely accepted supraglottic airway device, whereas Laryseal™ Pro is a more recent addition to airway management options. Objectives: This study aimed to evaluate and compare the performance of Laryseal™ Pro and Ambu AuraGain, specifically focusing on oropharyngeal leak pressure (OLP) and insertion success rate. Patients and methods: Fifty-four adult patients were randomized into two equal groups: one receiving Laryseal™ Pro (L group) and the other Ambu AuraGain (A group). The primary endpoint was OLP five minutes post-insertion. Secondary measures included time required for insertion, success rate on first and second attempts, total number of insertion attempts, insertion ease score, OLP at subsequent time intervals (15, 30, 60 minutes), laryngeal view grading (based on Brimacombe and Berry scoring via flexible bronchoscopy), and incidence of postoperative complications such as sore throat, dysphagia, and blood-streaked secretions. Results: OLP values at all time points were significantly higher in the Laryseal™ Pro group. Insertion time was shorter for the L group compared to the A group. Only 3.7% of patients in Group L required neck extension during insertion, in contrast to 96.2% in Group A, showing a statistically significant difference. Hemodynamic parameters remained comparable between groups. Grade 1 laryngeal view was observed in 59.3% of Group L and 44.4% of Group A, with no significant difference. Postoperative side effects were similar across both groups. Conclusion: Laryseal™ Pro showed superior OLP and faster insertion compared to Ambu AuraGain, supporting its potential use as a reliable supraglottic airway in adult patients undergoing elective ophthalmic procedures under general anesthesia. | ||||
| Keywords | ||||
| Supraglottic airway devices; Oropharyngeal leak pressure; Airway management; Positive pressure ventilation | ||||
|
Statistics Article View: 84 PDF Download: 39 |
||||
